Casaburi Eric
Known title: DirectorCIK: 0001990853
Casaburi Eric's purchase track record
How the stock did after each of Casaburi Eric's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
6
of 6 since February 16, 2024
Stock higher 6 months later
50%
3 months: 33%
Median 6-month return
-26.2%
3 months: -16.2%
Beat the S&P 500
33%
median -30.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/15/2025 | ONMD | $31K | -60.3% | -68.2% | +5.3% |
| 11/20/2024 | ONMD | $1K | +12.9% | -54.3% | -1.2% |
| 11/12/2024 | ONMD | $425 | -1.5% | -55.9% | -1.6% |
| 7/8/2024 | ONMD | $4K | -30.9% | +46.9% | +7.2% |
| 2/29/2024 | ONMD | $2K | +166.1% | +1.9% | +9.7% |
| 2/16/2024 | ONMD | $2K | -51.0% | +37.9% | +11.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ONMD | ▲ Buy | Grant | 45,000 | $0 | 11/26/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 10,000 | $31K | 10/15/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 1,300 | $1K | 11/20/2024 | View on chart |
| ONMD | ▲ Buy | Open Market | 500 | $425 | 11/12/2024 | View on chart |
| ONMD | ▲ Buy | Open Market | 4,100 | $4K | 7/8/2024 | View on chart |
| ONMD | ▲ Buy | Open Market | 2,000 | $1K | 3/5/2024 | View on chart |
| ONMD | ▲ Buy | Open Market | 575 | $414 | 2/29/2024 | View on chart |
| ONMD | ▲ Buy | Open Market | 2,000 | $2K | 2/16/2024 | View on chart |
| ONMD | ▲ Buy | Grant | 45,000 | $0 | 1/19/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split
OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.
ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split. OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.